Moreover, constitutive activation of STAT3 is observed in approximately 60% of HCC patients compared with healthy controls, possibly owing to elevated IL-6 levels or dysfunction of STAT3 negative regulators [39]. Here, IL6 is linked to hepatocellular carcinoma.